v3.25.4
SHARE BASED COMPENSATION - Options Granted and Valuation assumptions (Details)
3 Months Ended 12 Months Ended
Dec. 31, 2025
CAD ($)
Y
shares
$ / shares
Sep. 30, 2025
shares
SHARE BASED COMPENSATION    
Options Granted | shares 100,351 514,937
October 15, 2030    
SHARE BASED COMPENSATION    
Options Granted | shares 100,351  
Exercise Price $ 5.09  
Fair Value | $ $ 416,876  
Fair Value per Option $ 4.15  
Share Price at Grant $ 4.85  
Volatility 129.10%  
Risk-Free Rate 2.42%  
Expected life | Y 5  
October 15, 2030 | Tranche one    
SHARE BASED COMPENSATION    
Share options, vesting percentage 0.50%  
Share options, vesting period 12 months  
October 15, 2030 | Tranche two    
SHARE BASED COMPENSATION    
Share options, vesting percentage 0.50%  
Share options, vesting period 12 months  
August 28, 2030    
SHARE BASED COMPENSATION    
Options Granted | shares 37,500  
Exercise Price $ 11.13  
Fair Value | $ $ 359,000  
Fair Value per Option $ 9.57  
Share Price at Grant $ 11.13  
Volatility 128.40%  
Risk-Free Rate 2.69%  
Expected life | Y 5  
August 28, 2030 | Tranche one    
SHARE BASED COMPENSATION    
Share options, vesting percentage 0.33%  
Share options, vesting period 12 months  
August 28, 2030 | Tranche two    
SHARE BASED COMPENSATION    
Share options, vesting percentage 0.67%  
Share options, vesting period 24 months  
July 24, 2030    
SHARE BASED COMPENSATION    
Options Granted | shares 130,000  
Exercise Price $ 8.48  
Fair Value | $ $ 947,000  
Fair Value per Option $ 7.28  
Share Price at Grant $ 8.48  
Volatility 128.30%  
Risk-Free Rate 2.83%  
Expected life | Y 5  
Share options, vesting period 36 months  
July 23, 2030    
SHARE BASED COMPENSATION    
Options Granted | shares 62,500  
Exercise Price $ 12  
Fair Value | $ $ 642,000  
Fair Value per Option $ 10.27  
Share Price at Grant $ 12  
Volatility 127.40%  
Risk-Free Rate 2.82%  
Expected life | Y 5  
Share options, vesting period 36 months  
June 3, 2030    
SHARE BASED COMPENSATION    
Options Granted | shares 31,250  
Exercise Price $ 22  
Fair Value | $ $ 610,000  
Fair Value per Option $ 19.52  
Share Price at Grant $ 23.44  
Volatility 118.50%  
Risk-Free Rate 2.86%  
Expected life | Y 5  
Share options, vesting period 36 months  
April 24, 2030    
SHARE BASED COMPENSATION    
Options Granted | shares 28,125  
Exercise Price $ 18  
Fair Value | $ $ 777,000  
Fair Value per Option $ 14.63  
Share Price at Grant $ 17.84  
Volatility 116.40%  
Risk-Free Rate 2.79%  
Expected life | Y 5  
April 24, 2030 | Tranche one    
SHARE BASED COMPENSATION    
Share options, vesting percentage 0.33%  
Share options, vesting period 6 months  
April 24, 2030 | Tranche two    
SHARE BASED COMPENSATION    
Share options, vesting percentage 0.67%  
Share options, vesting period 24 months  
April 24, 2030    
SHARE BASED COMPENSATION    
Options Granted | shares 53,125  
Exercise Price $ 18  
Fair Value | $ $ 777,000  
Fair Value per Option $ 14.63  
Share Price at Grant $ 17.84  
Volatility 116.40%  
Risk-Free Rate 2.79%  
Expected life | Y 5  
April 24, 2030 | Tranche one    
SHARE BASED COMPENSATION    
Share options, vesting percentage 0.33%  
Share options, vesting period 12 months  
April 24, 2030 | Tranche two    
SHARE BASED COMPENSATION    
Share options, vesting percentage 0.67%  
Share options, vesting period 24 months  
March 17, 2030    
SHARE BASED COMPENSATION    
Options Granted | shares 6,250  
Exercise Price $ 18.8  
Fair Value | $ $ 101,916  
Fair Value per Option $ 16.31  
Share Price at Grant $ 18.8  
Volatility 131.40%  
Risk-Free Rate 2.69%  
Expected life | Y 5  
Share options, vesting period 12 months  
March 17, 2030    
SHARE BASED COMPENSATION    
Options Granted | shares 500,000  
Exercise Price $ 19.04  
Fair Value | $ $ 971,331  
Fair Value per Option $ 1.94  
Share Price at Grant $ 18.8  
Volatility 124.90%  
Risk-Free Rate 2.69%  
Expected life | Y 5  
Share options, vesting period 36 months  
February 28, 2030    
SHARE BASED COMPENSATION    
Options Granted | shares 37,500  
Exercise Price $ 21.68  
Fair Value | $ $ 708,537  
Fair Value per Option $ 18.89  
Share Price at Grant $ 21.68  
Volatility 132.90%  
Risk-Free Rate 2.60%  
Expected life | Y 5  
Share options, vesting period 12 months  
January 30, 2030    
SHARE BASED COMPENSATION    
Options Granted | shares 50,000  
Exercise Price $ 39.28  
Fair Value | $ $ 1,719,366  
Fair Value per Option $ 34.39  
Share Price at Grant $ 39.28  
Volatility 134.20%  
Risk-Free Rate 2.79%  
Expected life | Y 5  
November 27, 2029    
SHARE BASED COMPENSATION    
Options Granted | shares 9,375  
Exercise Price $ 11.12  
Fair Value | $ $ 78,589  
Fair Value per Option $ 8.38  
Share Price at Grant $ 11.12  
Volatility 99.40%  
Risk-Free Rate 3.13%  
Expected life | Y 5  
October 29, 2029    
SHARE BASED COMPENSATION    
Options Granted | shares 34,937  
Exercise Price $ 16.16  
Fair Value | $ $ 425,291  
Fair Value per Option $ 12.17  
Share Price at Grant $ 16.16  
Volatility 99.40%  
Risk-Free Rate 3.04%  
Expected life | Y 5